Latestage vaccine trials resume after Brazil pause
2020-11-13 00:00
After a brief pause, Brazil has restarted latestage trials for a COVID vaccine candidate developed by Chinese drugmaker Sinovac Biotech.Brazilian health regulator Anvisa said in a statement on Wednesday that it had evaluated enough information to allow the resumption of vaccination. The trials of the candidate vaccine, CoronaVac, had been suspended after serious adverse event, believed to be the death of a volunteer.It is important to clarify that a suspension does not necessarily mean that the product under investigation lacks quality, safety or efficacy, the regulator said.                                                                                                                                                                                                                                                                           !CDATA            function shareweixin              var ua  navigator.userAgent.toLowerCase              ifiphoneipadipod.testua  ua.matchMicroMessengeri  micromessenger                window.opena.app.qq.comosimple.jsp?pkgnamecom.theotino.chinadailyiosschemeencodeIos                            else ifandroid.testua  ua.matchMicroMessengeri  micromessenger                window.opena.app.qq.comosimple.jsp?pkgnamecom.theotino.chinadailyandroidschemeencodeAndroid                            else                window.openwww.chinadaily.com.cnmobiledaily.html